Phase II comparison of accelerated twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with etoposide and cisplati

Completed

• Conditions: Cancer: Limited small-cell lung cancer; Limited small-cell lung cancer; Cancer

• Registration Number: ISRCTN54145633
• Lead Sponsor: Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 81

Inclusion Criteria

Patients who are =75 years of age with histologically proven small-cell lung cancer and fully meet the criteria will be approached for consent. 81 Patients in total will be recruited for the trial and 27 will be recruited to the standard arm and 54 to the experimental arm. 25 patients per year.

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified